Oncology Coding Break – Grade Coding Updates

Oncology, Oncology Coding Break, Registry Education

<a href="https://www.registrypartners.com/author/monica-reece/" target="_self">Monica Reece</a>

Monica Reece

Quality Consultant

Published/Updated Date: February 26, 2024

The February 2024 Registry Partners Oncology Coding Break presents the topic of grade coding updates. The grade manual coding instructions are reviewed beginning with autopsy grading that has been added to the manual. The findings from the autopsy direct the ODS-C to the correct grade time frame (clinical, post-therapy clinical, pathological, and post therapy pathological) and we cannot assume autopsy grade should be assigned to pathological grade per the instructions. 

The grade manual added instructions for endometrioid schema, which included assigning code 2 if low grade is documented and assigning code 3 when high grade is documented. Version 9 for brain, CNS Other, and Intracranial Gland schema has updated instructions for code 2 WHO Grade II, code 3 WHO Grade III, and code 4 WHO Grade IV. Also, there have been clarifications for grade post therapy path (yp) and grade pathological. Note 6 for each data item has been updated under code 9 for unknown. Lastly, the general grade coding instructions for solid tumor rules has a new #4 general guideline for priority. A priority for grade has been added to include synoptic reporting as first priority, then pathology report final diagnosis before taking a physician statement. There are case examples throughout the presentation to assist with in-sight to grade coding updates.

Click here to download this month’s presentation as a PDF.

Related

How AI Is Changing Registry Workflows

How AI Is Changing Registry Workflows

Artificial intelligence is quickly becoming part of healthcare operations. As registry programs face increasing case complexity, growing documentation requirements, staffing challenges, and pressure to deliver reliable data more efficiently, organizations are...

Childhood Cancer Awareness Month: Why Every Case Matters

Childhood Cancer Awareness Month: Why Every Case Matters

In September, Childhood Cancer Awareness Month draws attention to the children and their families who are affected by cancer and to the ongoing need for research, treatment advances, and support. It also provides a chance to acknowledge something more invisible. The...

Stay in Touch

Get our latest articles, registry insights, and company news straight to your inbox.

This field is for validation purposes and should be left unchanged.